Home Politics Religion Media Biz Society Tech Travel Books Intl. Autos Automobiles
                        Aviation   Pharma   About Us   Feedback   Links
DANGERS IN TRADITIONAL CHINESE HERBAL MEDICINES
 

Chinese herbal products could be dangerous: UK

Some traditional Chinese herbal medicines and remedies could be dangerous, says MHRA.

BY OUR PHARMA CORRESPONDENT

20 September,2005: The British health authorities warned the consumers some traditional Chinese medicines (TCM) in the UK market could pose health risks.

Alerting the herbal sector about the poor quality of some traditional herbal medicines, the Medicines and Healthcare products Regulatory Agency (MHRA) of UK has recently identified a number of TCMs which contain ingredients that could pose a risk to consumers' health.

The regulatory watch-dog reminded consumers through an official release that they cannot give assurances about the quality of these unlicensed traditional herbal medicines and remedies and to give an update on action to address the problem.

Under current regulations, unlicensed herbal medicines, from China or anywhere else, do not have to meet set standards of quality and safety. However, if these herbal products are found containing illegal or potent ingredients, such as prescription-only medicines, the MHRA can remove them from sale, said the release.

Examples of incidents Chinese herbals currently being investigated by MHRA include:

- The Chinese dietary supplement, Shubao; samples of this herbal dietary supplement have been found to contain fenfluramine (banned worldwide after being linked with cardiac problems) and/or nitrosfenfluramine (toxic to the liver); - 

Fufang luhui jiaonang, supplied by a Traditional Chinese herbal medicine outlet was investigated by the agency and found to contain high levels of mercury - 11.7% by weight. The product was recalled from 35 TCM outlets.

Other ingredients found to be illegally included in Traditional Chinese herbal medicines in recent months have included the banned ingredient Aristolochia, associated with kidney failure and cancer; prescription-only ingredients glibenclamide (used in the treatment of diabetes; improper use can be fatal) and corticosteroids (found in 'herbal' skin creams). The TCMs involved have been in a number of forms, including pills and capsules.

Sir Alasdair Breckenridge, chair of the MHRA, said: "Our advice to consumers is not to take TCMs if they are not labelled in English. Even then you should be aware that good labelling is not a guarantee of a good quality product. If you are taking one of the specific traditional chinese medicines identified as posing a risk, stop taking it and consult your GP if you feel unwell. When consulting your doctor or pharmacist about your health, always remember to tell them if you are taking TCMs or other herbal remedies."

The European Directive on Traditional Herbal Medicinal Products will set out clear standards for the safety and quality of over the counter traditional herbal medicines and is due to be implemented in 2005.

BY OUR PHARMA CORRESPONDENT

 

   Pharma Home
LATEST UPDATES

Chinese herbal products could be dangerous: UK 

Knock, knock! It's bird flu at the door

Spider anti-venom to be stocked in UAE hospital 

US may ban animal protein in cattle feed to safeguard against mad cow 

Dr Reddy's nizatidine generic gets FDA nod

Late-onset Pompe disease drug goes on trial

First biologic to treat ulcerative colitis gets US FDA okay

Diverticulitis orally dissolving pill from KV Pharma's  hits the market

Impax delisted from Nasdaq

US FDA okays Lupin's cephalexin

Hepatitis C combo therapy to get priority review in Japan

Lung cancer vaccine trials promising: Introgen

Sugar-free pill Actiq for cancer pain

39 drug firms sued over price rigging in California

Anti fungal terbinafine launched in Europe: Actavis

HIV entry blocking drug data encouraging: Progenics

Allegra generic to be launched in US

Long-acting pain drug data positive: Pain Therapeutics

New kidney cancer drug seeks EU nod

Inhaled insulin may get US FDA clearance

A vaccine against fungus is on way

Enzyme stops progression of HIV in survivors, confirms study

Aclasta found faster-acting in Paget's disease treatment

Beta blocker can start therapy in heart failure: Merck

Halobetasol generic launched in US

Anemia drug darbepoetin's late-stage studies begin: Amgen

Cholesterol generic gets marketing nod in US: Par

Aricept for severe Alzheimer’s disease too: Eisai

Bone regeneration trials begin in US:Mesoblast

New dye to detect early Alzheimer's

Breast forming gene discovered

Thyroid drug to be supplied by IVAX in US

Rituxan, cancer drug can treat rheumatoid arthritis

Yasminelle, low-dose oral contraceptive approved in the Netherlands

Fluarix, anti-flu shot by Glaxo approved

Increlex, drug to treat `abnormally short’ kids approved in US

Anti-HIV drugs prices cut: Gilead

US FDA approves Takeda’s drug combo for type 2 diabetes

Novartis’ drug for breast cancer recurrence to be given priority review in US

US puts off decision on contraceptive pill again

Shire’s ADHD drug Adderall back on list in Canada

WHO calls for emergency action to halt TB in Africa

Some of the Vioxx suits may be settled: Merck

Nasdaq delists Able on bankruptcy filing

Hospira ships ceftriaxone generics to US

Renovis stops sciatica drug studies

 

Home Politics Religion Media Biz Society Tech Travel Books Intl. Autos Automobiles
                        Aviation   Pharma   About Us   Feedback   Links

Latest updates    Contact Us - Feedback    About Us